academic article

• SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV..  DNA repair.  43:18-23. 2016
• Regulatory and clinical considerations for biosimilar oncology drugs..  The Lancet. Oncology.  15:e594-e605. 2014